Global Tinea Corporis Drugs Market Size, Status and Forecast 2020-2026

August 2020 | 95 pages | ID: G230CC227F9FEN
QYResearch

Abstracts

This report focuses on the global Tinea Corporis Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Tinea Corporis Drugs development in North America, Europe and Asia-Pacific, Southeast Asia, India and Central & South America.

The key players covered in this study

• Sun Pharmaceutical
• Teva
• Glenmark
• Aurobindo
• AvKare
• Novartis
• Sebela
• Bayer

Market segment by Type, the product can be split into

• Antifungals
• Steroids
• Anti-Infective Combinations

Market segment by Application, split into

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Market segment by Regions/Countries, this report covers

• North America
• Europe
• Asia-Pacific
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Tinea Corporis Drugs status, future forecast, growth opportunity, key market and key players.
• To present the Tinea Corporis Drugs development in North America, Europe and Asia-Pacific, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Tinea Corporis Drugs are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Tinea Corporis Drugs Revenue
1.4 Market Analysis by Type
  1.4.1 Global Tinea Corporis Drugs Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Antifungals
  1.4.3 Steroids
  1.4.4 Anti-Infective Combinations
1.5 Market by Application
  1.5.1 Global Tinea Corporis Drugs Market Share by Application: 2020 VS 2026
  1.5.2 Hospital Pharmacies
  1.5.3 Retail Pharmacies
  1.5.4 Online Pharmacies
1.6 Coronavirus Disease 2019 (Covid-19): Tinea Corporis Drugs Industry Impact
  1.6.1 How the Covid-19 is Affecting the Tinea Corporis Drugs Industry
    1.6.1.1 Tinea Corporis Drugs Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Tinea Corporis Drugs Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Tinea Corporis Drugs Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Tinea Corporis Drugs Market Perspective (2015-2026)
2.2 Tinea Corporis Drugs Growth Trends by Regions
  2.2.1 Tinea Corporis Drugs Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Tinea Corporis Drugs Historic Market Share by Regions (2015-2020)
  2.2.3 Tinea Corporis Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Tinea Corporis Drugs Market Growth Strategy
  2.3.6 Primary Interviews with Key Tinea Corporis Drugs Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Tinea Corporis Drugs Players by Market Size
  3.1.1 Global Top Tinea Corporis Drugs Players by Revenue (2015-2020)
  3.1.2 Global Tinea Corporis Drugs Revenue Market Share by Players (2015-2020)
  3.1.3 Global Tinea Corporis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Tinea Corporis Drugs Market Concentration Ratio
  3.2.1 Global Tinea Corporis Drugs Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Tinea Corporis Drugs Revenue in 2019
3.3 Tinea Corporis Drugs Key Players Head office and Area Served
3.4 Key Players Tinea Corporis Drugs Product Solution and Service
3.5 Date of Enter into Tinea Corporis Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Tinea Corporis Drugs Historic Market Size by Type (2015-2020)
4.2 Global Tinea Corporis Drugs Forecasted Market Size by Type (2021-2026)

5 TINEA CORPORIS DRUGS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Tinea Corporis Drugs Market Size by Application (2015-2020)
5.2 Global Tinea Corporis Drugs Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Tinea Corporis Drugs Market Size (2015-2020)
6.2 Tinea Corporis Drugs Key Players in North America (2019-2020)
6.3 North America Tinea Corporis Drugs Market Size by Type (2015-2020)
6.4 North America Tinea Corporis Drugs Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Tinea Corporis Drugs Market Size (2015-2020)
7.2 Tinea Corporis Drugs Key Players in Europe (2019-2020)
7.3 Europe Tinea Corporis Drugs Market Size by Type (2015-2020)
7.4 Europe Tinea Corporis Drugs Market Size by Application (2015-2020)

8 ASIA-PACIFIC

8.1 Asia-Pacific Tinea Corporis Drugs Market Size (2015-2020)
8.2 Tinea Corporis Drugs Key Players in Asia-Pacific (2019-2020)
8.3 Asia-Pacific Tinea Corporis Drugs Market Size by Type (2015-2020)
8.4 Asia-Pacific Tinea Corporis Drugs Market Size by Application (2015-2020)
(2015-2020)
(2015-2020)

9 SOUTHEAST ASIA

9.1 Southeast Asia Tinea Corporis Drugs Market Size (2015-2020)
9.2 Tinea Corporis Drugs Key Players in Southeast Asia (2019-2020)
9.3 Southeast Asia Tinea Corporis Drugs Market Size by Type (2015-2020)
9.4 Southeast Asia Tinea Corporis Drugs Market Size by Application (2015-2020)

10 INDIA

10.1 India Tinea Corporis Drugs Market Size (2015-2020)
10.2 Tinea Corporis Drugs Key Players in India (2019-2020)
10.3 India Tinea Corporis Drugs Market Size by Type (2015-2020)
10.4 India Tinea Corporis Drugs Market Size by Application (2015-2020)

11 CENTRAL & SOUTH AMERICA

11.1 Central & South America Tinea Corporis Drugs Market Size (2015-2020)
11.2 Tinea Corporis Drugs Key Players in Central & South America (2019-2020)
11.3 Central & South America Tinea Corporis Drugs Market Size by Type (2015-2020)
11.4 Central & South America Tinea Corporis Drugs Market Size by Application (2015-2020)

12 KEY PLAYERS PROFILES

12.1 Sun Pharmaceutical
  12.1.1 Sun Pharmaceutical Company Details
  12.1.2 Sun Pharmaceutical Business Overview and Its Total Revenue
  12.1.3 Sun Pharmaceutical Tinea Corporis Drugs Introduction
  12.1.4 Sun Pharmaceutical Revenue in Tinea Corporis Drugs Business (2015-2020))
  12.1.5 Sun Pharmaceutical Recent Development
12.2 Teva
  12.2.1 Teva Company Details
  12.2.2 Teva Business Overview and Its Total Revenue
  12.2.3 Teva Tinea Corporis Drugs Introduction
  12.2.4 Teva Revenue in Tinea Corporis Drugs Business (2015-2020)
  12.2.5 Teva Recent Development
12.3 Glenmark
  12.3.1 Glenmark Company Details
  12.3.2 Glenmark Business Overview and Its Total Revenue
  12.3.3 Glenmark Tinea Corporis Drugs Introduction
  12.3.4 Glenmark Revenue in Tinea Corporis Drugs Business (2015-2020)
  12.3.5 Glenmark Recent Development
12.4 Aurobindo
  12.4.1 Aurobindo Company Details
  12.4.2 Aurobindo Business Overview and Its Total Revenue
  12.4.3 Aurobindo Tinea Corporis Drugs Introduction
  12.4.4 Aurobindo Revenue in Tinea Corporis Drugs Business (2015-2020)
  12.4.5 Aurobindo Recent Development
12.5 AvKare
  12.5.1 AvKare Company Details
  12.5.2 AvKare Business Overview and Its Total Revenue
  12.5.3 AvKare Tinea Corporis Drugs Introduction
  12.5.4 AvKare Revenue in Tinea Corporis Drugs Business (2015-2020)
  12.5.5 AvKare Recent Development
12.6 Novartis
  12.6.1 Novartis Company Details
  12.6.2 Novartis Business Overview and Its Total Revenue
  12.6.3 Novartis Tinea Corporis Drugs Introduction
  12.6.4 Novartis Revenue in Tinea Corporis Drugs Business (2015-2020)
  12.6.5 Novartis Recent Development
12.7 Sebela
  12.7.1 Sebela Company Details
  12.7.2 Sebela Business Overview and Its Total Revenue
  12.7.3 Sebela Tinea Corporis Drugs Introduction
  12.7.4 Sebela Revenue in Tinea Corporis Drugs Business (2015-2020)
  12.7.5 Sebela Recent Development
12.8 Bayer
  12.8.1 Bayer Company Details
  12.8.2 Bayer Business Overview and Its Total Revenue
  12.8.3 Bayer Tinea Corporis Drugs Introduction
  12.8.4 Bayer Revenue in Tinea Corporis Drugs Business (2015-2020)
  12.8.5 Bayer Recent Development

13 ANALYST'S VIEWPOINTS/CONCLUSIONS

14 APPENDIX

14.1 Research Methodology
  14.1.1 Methodology/Research Approach
  14.1.2 Data Source
14.2 Disclaimer
14.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Tinea Corporis Drugs Key Market Segments
Table 2. Key Players Covered: Ranking by Tinea Corporis Drugs Revenue
Table 3. Ranking of Global Top Tinea Corporis Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Tinea Corporis Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Antifungals
Table 6. Key Players of Steroids
Table 7. Key Players of Anti-Infective Combinations
Table 8. COVID-19 Impact Global Market: (Four Tinea Corporis Drugs Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Tinea Corporis Drugs Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Tinea Corporis Drugs Players to Combat Covid-19 Impact
Table 13. Global Tinea Corporis Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Tinea Corporis Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Tinea Corporis Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Tinea Corporis Drugs Market Share by Regions (2015-2020)
Table 17. Global Tinea Corporis Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Tinea Corporis Drugs Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Tinea Corporis Drugs Market Growth Strategy
Table 23. Main Points Interviewed from Key Tinea Corporis Drugs Players
Table 24. Global Tinea Corporis Drugs Revenue by Players (2015-2020) (Million US$)
Table 25. Global Tinea Corporis Drugs Market Share by Players (2015-2020)
Table 26. Global Top Tinea Corporis Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tinea Corporis Drugs as of 2019)
Table 27. Global Tinea Corporis Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Tinea Corporis Drugs Product Solution and Service
Table 30. Date of Enter into Tinea Corporis Drugs Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Tinea Corporis Drugs Market Size by Type (2015-2020) (Million US$)
Table 33. Global Tinea Corporis Drugs Market Size Share by Type (2015-2020)
Table 34. Global Tinea Corporis Drugs Revenue Market Share by Type (2021-2026)
Table 35. Global Tinea Corporis Drugs Market Size Share by Application (2015-2020)
Table 36. Global Tinea Corporis Drugs Market Size by Application (2015-2020) (Million US$)
Table 37. Global Tinea Corporis Drugs Market Size Share by Application (2021-2026)
Table 38. North America Key Players Tinea Corporis Drugs Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Tinea Corporis Drugs Market Share (2019-2020)
Table 40. North America Tinea Corporis Drugs Market Size by Type (2015-2020) (Million US$)
Table 41. North America Tinea Corporis Drugs Market Share by Type (2015-2020)
Table 42. North America Tinea Corporis Drugs Market Size by Application (2015-2020) (Million US$)
Table 43. North America Tinea Corporis Drugs Market Share by Application (2015-2020)
Table 44. Europe Key Players Tinea Corporis Drugs Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Tinea Corporis Drugs Market Share (2019-2020)
Table 46. Europe Tinea Corporis Drugs Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Tinea Corporis Drugs Market Share by Type (2015-2020)
Table 48. Europe Tinea Corporis Drugs Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Tinea Corporis Drugs Market Share by Application (2015-2020)
Table 50. Asia-Pacific Key Players Tinea Corporis Drugs Revenue (2019-2020) (Million US$)
Table 51. Asia-Pacific Key Players Tinea Corporis Drugs Market Share (2019-2020)
Table 52. Asia-Pacific Tinea Corporis Drugs Market Size by Type (2015-2020) (Million US$)
Table 53. Asia-Pacific Tinea Corporis Drugs Market Share by Type (2015-2020)
Table 54. Asia-Pacific Tinea Corporis Drugs Market Size by Application (2015-2020) (Million US$)
Table 55. Asia-Pacific Tinea Corporis Drugs Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Tinea Corporis Drugs Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Tinea Corporis Drugs Market Share (2019-2020)
Table 58. Southeast Asia Tinea Corporis Drugs Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Tinea Corporis Drugs Market Share by Type (2015-2020)
Table 60. Southeast Asia Tinea Corporis Drugs Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Tinea Corporis Drugs Market Share by Application (2015-2020)
Table 62. India Key Players Tinea Corporis Drugs Revenue (2019-2020) (Million US$)
Table 63. India Key Players Tinea Corporis Drugs Market Share (2019-2020)
Table 64. India Tinea Corporis Drugs Market Size by Type (2015-2020) (Million US$)
Table 65. India Tinea Corporis Drugs Market Share by Type (2015-2020)
Table 66. India Tinea Corporis Drugs Market Size by Application (2015-2020) (Million US$)
Table 67. India Tinea Corporis Drugs Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Tinea Corporis Drugs Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Tinea Corporis Drugs Market Share (2019-2020)
Table 70. Central & South America Tinea Corporis Drugs Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Tinea Corporis Drugs Market Share by Type (2015-2020)
Table 72. Central & South America Tinea Corporis Drugs Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Tinea Corporis Drugs Market Share by Application (2015-2020)
Table 74. Sun Pharmaceutical Company Details
Table 75. Sun Pharmaceutical Business Overview
Table 76. Sun Pharmaceutical Product
Table 77. Sun Pharmaceutical Revenue in Tinea Corporis Drugs Business (2015-2020) (Million US$)
Table 78. Sun Pharmaceutical Recent Development
Table 79. Teva Company Details
Table 80. Teva Business Overview
Table 81. Teva Product
Table 82. Teva Revenue in Tinea Corporis Drugs Business (2015-2020) (Million US$)
Table 83. Teva Recent Development
Table 84. Glenmark Company Details
Table 85. Glenmark Business Overview
Table 86. Glenmark Product
Table 87. Glenmark Revenue in Tinea Corporis Drugs Business (2015-2020) (Million US$)
Table 88. Glenmark Recent Development
Table 89. Aurobindo Company Details
Table 90. Aurobindo Business Overview
Table 91. Aurobindo Product
Table 92. Aurobindo Revenue in Tinea Corporis Drugs Business (2015-2020) (Million US$)
Table 93. Aurobindo Recent Development
Table 94. AvKare Company Details
Table 95. AvKare Business Overview
Table 96. AvKare Product
Table 97. AvKare Revenue in Tinea Corporis Drugs Business (2015-2020) (Million US$)
Table 98. AvKare Recent Development
Table 99. Novartis Company Details
Table 100. Novartis Business Overview
Table 101. Novartis Product
Table 102. Novartis Revenue in Tinea Corporis Drugs Business (2015-2020) (Million US$)
Table 103. Novartis Recent Development
Table 104. Sebela Company Details
Table 105. Sebela Business Overview
Table 106. Sebela Product
Table 107. Sebela Revenue in Tinea Corporis Drugs Business (2015-2020) (Million US$)
Table 108. Sebela Recent Development
Table 109. Bayer Business Overview
Table 110. Bayer Product
Table 111. Bayer Company Details
Table 112. Bayer Revenue in Tinea Corporis Drugs Business (2015-2020) (Million US$)
Table 113. Bayer Recent Development
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Tinea Corporis Drugs Market Share by Type: 2020 VS 2026
Figure 2. Antifungals Features
Figure 3. Steroids Features
Figure 4. Anti-Infective Combinations Features
Figure 5. Global Tinea Corporis Drugs Market Share by Application: 2020 VS 2026
Figure 6. Hospital Pharmacies Case Studies
Figure 7. Retail Pharmacies Case Studies
Figure 8. Online Pharmacies Case Studies
Figure 9. Tinea Corporis Drugs Report Years Considered
Figure 10. Global Tinea Corporis Drugs Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Tinea Corporis Drugs Market Share by Regions: 2020 VS 2026
Figure 12. Global Tinea Corporis Drugs Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Tinea Corporis Drugs Market Share by Players in 2019
Figure 15. Global Top Tinea Corporis Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tinea Corporis Drugs as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Tinea Corporis Drugs Revenue in 2019
Figure 17. North America Tinea Corporis Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Tinea Corporis Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Asia-Pacific Tinea Corporis Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Tinea Corporis Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Tinea Corporis Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Tinea Corporis Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Sun Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Sun Pharmaceutical Revenue Growth Rate in Tinea Corporis Drugs Business (2015-2020)
Figure 25. Teva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Teva Revenue Growth Rate in Tinea Corporis Drugs Business (2015-2020)
Figure 27. Glenmark Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Glenmark Revenue Growth Rate in Tinea Corporis Drugs Business (2015-2020)
Figure 29. Aurobindo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Aurobindo Revenue Growth Rate in Tinea Corporis Drugs Business (2015-2020)
Figure 31. AvKare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. AvKare Revenue Growth Rate in Tinea Corporis Drugs Business (2015-2020)
Figure 33. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Novartis Revenue Growth Rate in Tinea Corporis Drugs Business (2015-2020)
Figure 35. Sebela Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Sebela Revenue Growth Rate in Tinea Corporis Drugs Business (2015-2020)
Figure 37. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Bayer Revenue Growth Rate in Tinea Corporis Drugs Business (2015-2020)
Figure 39. Bottom-up and Top-down Approaches for This Report
Figure 40. Data Triangulation
Figure 41. Key Executives Interviewed